Clinical Trials Browser

Phase 2 × Carcinoma, Intraductal, Noninfiltrating × darolutamide × Clear all

NCT04176081 2024-01-24

SChLAP/IDC

Phase 2 Not yet recruiting

BreastGenitourinary

Carcinoma, Intraductal, Noninfiltrating, Prostatic Neoplasms